Venturi Wealth Management LLC Has $587,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Venturi Wealth Management LLC boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 35.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,381 shares of the medical device company’s stock after purchasing an additional 1,682 shares during the quarter. Venturi Wealth Management LLC’s holdings in Cooper Companies were worth $587,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of COO. Ashton Thomas Securities LLC bought a new position in Cooper Companies in the third quarter valued at about $25,000. Covestor Ltd grew its position in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Byrne Asset Management LLC bought a new position in Cooper Companies in the fourth quarter valued at about $33,000. Brown Brothers Harriman & Co. grew its position in Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the last quarter. Finally, Cromwell Holdings LLC bought a new position in Cooper Companies in the third quarter valued at about $52,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $86.46 on Thursday. The stock’s 50 day moving average is $93.23 and its 200 day moving average is $99.65. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $17.26 billion, a P/E ratio of 44.34, a P/E/G ratio of 2.23 and a beta of 1.00. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 earnings per share. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company boosted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.